JPMORGAN CHASE & CO - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is and the CUSIP is 75615P903. A total of 5 filers reported holding REATA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$28,185,000310,0000.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 131,400$11,946,8880.04%
SIMPLEX TRADING, LLC 94,300$8,5730.01%
JANE STREET GROUP, LLC 97,400$8,855,6080.00%
JPMORGAN CHASE & CO 310,000$28,185,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of REATA PHARMACEUTICALS INC shareholders